Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " August 29, 2007":" September 28, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir
22 Completed
Has Results
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)
Condition: HIV Infections
Interventions: Drug: tenofovir DF 300 mg QD;   Drug: emtricitabine 200 mg QD;   Drug: Nevirapine 200 mg BID;   Drug: Atazanavir 300 mg;   Drug: Ritonavir 100 mg
23 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
24 Completed Raltegravir Insulin Sensitivity Study
Condition: HIV Infections
Interventions: Drug: Raltegravir then lopinavir/ritonavir;   Drug: Lopinavir/ritonavir then raltegravir
25 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
26 Completed Interactions Between HIV and Malaria in African Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: Dihydroartemisinin-piperaquine;   Drug: Artemether-lumefantrine;   Drug: Trimethoprim-sulfamethoxazole
27 Withdrawn Epoetin Alfa for HIV-Associated Neuropathy Trial
Conditions: HIV Infections;   Neuropathy
Intervention: Drug: epoetin alfa
28 Terminated A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: efavirenz or nevirapine
29 Completed
Has Results
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Conditions: Genital Herpes;   HIV Infection
Interventions: Drug: valacyclovir;   Drug: acyclovir
30 Terminated Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: efavirenz
31 Completed Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: Peginterferon alfa-2a plus ribavirin adjusted to body weight
32 Completed
Has Results
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Condition: Human Immunodeficiency Virus - Type 1
Interventions: Drug: Darunavir (DRV);   Drug: Ritonavir (rtv)
33 Active, not recruiting The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
Conditions: HIV Infections;   Diarrhea;   Bacterial Vaginosis
Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14;   Dietary Supplement: Placebo;   Drug: Metronidazole
34 Completed
Has Results
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
Condition: HIV-1 Infection
Intervention: Drug: TMC125; darunavir; ritonavir
35 Completed Evaluation of Albuminuria HIV-Infected Patients
Conditions: HIV-Associated Focal Segmental Glomerulosclerosis;   HIV-Associated Collapsing Glomerulopathy;   Proteinuria;   Albuminuria;   Renal Tubular Toxicity
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Study has passed its completion date and status has not been verified in more than two years.